Phathom Pharmaceuticals, Inc. PHAT Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s free cash flow margin?
- Phathom Pharmaceuticals, Inc. (PHAT) reported free cash flow margin of -47.7% in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s free cash flow margin changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s free cash flow margin increased by 86.2% year-over-year, from -345.5% to -47.7%.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s free cash flow margin?
- Over 2 years (2023 to 2025), Phathom Pharmaceuticals, Inc.'s free cash flow margin has grown at a -93.2% compound annual growth rate (CAGR), from -20,412.6% to -95.4%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.